Literature DB >> 12048077

Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery.

Bei Huang1, Thomas Dreyer, Martin Heidt, Julie C M Yu, Monika Philipp, Friedrich W Hehrlein, Norbert Katz, Nadia Al-Fakhri.   

Abstract

OBJECTIVE: In arteriosclerosis and bypass graft stenosis, intimal proliferation is controlled by local and systemic growth factors, such as platelet derived growth factor (PDGF) or insulin. Intimal hyperplasia can be produced in organ culture models. Our aim was to compare neointima formation in two organ culture models of internal mammary artery (IMA) and saphenous vein (SV), with special reference to the influence of systemic and local growth stimuli.
METHODS: Rings of freshly isolated human SV and IMA were cultured over a 3-, 6- or 8-day period. They were distributed into five groups of incubation protocols: incubation with 10% serum; insulin 50 ng/ml and 100 ng/ml; PDGF-BB 5 ng/ml and 10 ng/ml. Frozen sections of cultured rings and pre-culture segments were subjected to elastic stain and immunohistochemistry. Antibodies directed against beta-actin and smooth muscle alpha-actin were used to characterize smooth muscle cell phenotype and against proliferating cell nuclear antigen (PCNA) to demonstrate proliferating cells.
RESULTS: Growth factor incubation caused massive intimal hyperplasia with increased elastic fibers in SV and intimal smooth muscle cell as well as matrix accumulation in IMA. Intimal thickening, PCNA and beta-actin expression reached their maximum on day 6 of culture. In both culture models, serum, insulin and PDGF caused increasing intimal thickening, with more pronounced effects in SV.
CONCLUSIONS: These organ culture models demonstrate the effects of insulin and PDGF on intimal hyperplasia in IMA and SV representing models for arteriosclerosis and bypass graft stenosis and stressing the role of insulin and growth factors for neointima development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048077     DOI: 10.1016/s1010-7940(02)00111-2

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions.

Authors:  Y Kobayashi; K Naruse; Y Hamada; E Nakashima; K Kato; N Akiyama; H Kamiya; A Watarai; M Nakae; Y Oiso; J Nakamura
Journal:  Diabetologia       Date:  2005-09-30       Impact factor: 10.122

2.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

Review 3.  Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.

Authors:  Akihito Muto; Lynn Model; Kenneth Ziegler; Sammy D D Eghbalieh; Alan Dardik
Journal:  Circ J       Date:  2010-07-01       Impact factor: 2.993

4.  Ex vivo culture of human atherosclerotic plaques: A model to study immune cells in atherogenesis.

Authors:  Anna Lebedeva; Daria Vorobyeva; Murad Vagida; Oxana Ivanova; Eugeny Felker; Wendy Fitzgerald; Natalya Danilova; Vladimir Gontarenko; Alexander Shpektor; Elena Vasilieva; Leonid Margolis
Journal:  Atherosclerosis       Date:  2017-10-07       Impact factor: 5.162

Review 5.  Neo-intimal hyperplasia, diabetes and endovascular injury.

Authors:  Deirdre Kruger
Journal:  Cardiovasc J Afr       Date:  2012-05-22       Impact factor: 1.167

6.  Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells.

Authors:  Guanghong Jia; Anshu Aggarwal; Amanuel Yohannes; Deepak M Gangahar; Devendra K Agrawal
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

Review 7.  The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.

Authors:  Chris P H Lexis; Braim M Rahel; Joan G Meeder; Felix Zijlstra; Iwan C C van der Horst
Journal:  Cardiovasc Diabetol       Date:  2009-07-28       Impact factor: 9.951

8.  Molecular Action of Hydroxytyrosol in Attenuation of Intimal Hyperplasia: A Scoping Review.

Authors:  Ubashini Vijakumaran; Muhammad Dain Yazid; Ruszymah Bt Hj Idrus; Mohd Ramzisham Abdul Rahman; Nadiah Sulaiman
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

9.  Human saphenous vein organ culture under controlled hemodynamic conditions.

Authors:  Ayumi Aurea Miyakawa; Luis Alberto Oliveira Dallan; Silvia Lacchini; Thaiz Ferraz Borin; Jose Eduardo Krieger
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

10.  Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells.

Authors:  Alokkumar Pathak; Renyi Zhao; Jianhua Huang; George A Stouffer
Journal:  Cardiovasc Diabetol       Date:  2008-12-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.